Pressure-sensitive adhesives for transdermal drug delivery systems

Pharmaceutical Science and Technology Today

Volumn 2, Issue 2, 1999, Pages 60-69

  Tan, Hock S ^a   Pfister, William R ^a  

^a Lavipharm Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ACRYLIC ACID; ACRYLIC ACID BUTYL ESTER; ADHESIVE AGENT; CLONIDINE; COPOLYMER; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ETHYLENE VINYL ACETATE COPOLYMER; FENTANYL; GLYCERYL TRINITRATE; HARBITROL; HEXANE; ISOBUTYLENE; KARAYA GUM; NICOTINE; NORETHISTERONE ACETATE; PLASTICIZER; POLYACRYLIC ACID; POLYMER; POLYSILOXANE; RUBBER; SCOPOLAMINE; SILICONE; TESTOSTERONE; TOLUENE; UNCLASSIFIED DRUG;

ANGINA PECTORIS; BIOCOMPATIBILITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TRANSPORT; ELECTROPORATION; HUMAN; HYDROGEL; HYPERTENSION; HYPOGONADISM; IONTOPHORESIS; MOTION SICKNESS; OSTEOPOROSIS; PAIN; POSTMENOPAUSE; PRESSURE; REVIEW; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0033082677     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(99)00119-4     Document Type: Review

References (59)

1. Pfister, W.R. (1997) in Transdermal and Topical Drug Delivery Systems (Ghosh, T.K., Pfister, W.R. and Yum, S.I., eds), pp. 33-112, Interpharm Press, Buffalo Grove, IL, USA.
2. Kydonieus, A. (1987) in Transdermal Delivery of Drugs (Vol. 1) (Kydonieus, A. and Berner, B., eds), pp. 3-16, CRC Press.
3. Weissinger, J. (1993) in Dermal and Transdermal Drug Delivery (Gurny, R. and Teubner, A., eds), pp. 187-193, Wissenschaftliche Verlagsgesellschaft GmbH, Stuttgart, Germany.
4. Questel J. Adhesives & Sealants Industry. 2( 2):1995;28-36.
5. Benedek, I. and Heymans, L.J. (1997) Pressure-Sensitive Adhesives Technology, Marcel Dekker, New York, NY, USA.
6. Musolf, M.C. (1987) in Transdermal Controlled Systemic Medications (Chien, Y.W., ed.), pp. 93-112, Marcel Dekker, New York, NY, USA.
7. Ulman, K.L. and Thomas, X. (1995) in Advances in Pressure Sensitive Adhesive Technology - 2 (Satas, D., ed.), pp.133-157, Satas & Associates, Warwick, RI, USA.
8. Bova, D. et al. (1987) in Transdermal Controlled Systemic Medications (Chien, Y.W., ed.), pp. 379-396, Marcel Dekker, New York, NY, USA.
9. Peterson, T.A., Wick, S.M. and Ko, C. (1997) in Transdermal and Topical Drug Delivery Systems (Ghosh, T.K., Pfister, W.R. and Yum, S.I., eds), pp. 249-297, Interpharm Press, Buffalo Grove, IL, USA.
10. Barnhart S., Carrig T. Adhesives & Sealants Industry. 5( 3):1998;26-30.
11. Guy R.H. Pharm. Res. 13:1996;1765-1769.
12. Sun, Y. (1997) in Transdermal and Topical Drug Delivery Systems (Ghosh, T.K., Pfister, W.R. and Yum, S.I., eds), pp. 327-355, Interpharm Press, Buffalo Grove, IL, USA.
13. Satas, D. and Satas, A.M. (1989) in Handbook of Pressure Sensitive Adhesive Technology (Satas, D., ed.), pp. 627-642, Van Nostrand Reinhold, New York, NY, USA.
14. Higgins, J.J., Jagisch, F.C. and Stucker, N.E. (1989) in Handbook of Pressure Sensitive Adhesive Technology (Satas, D., ed.), pp. 374-395, Van Nostrand Reinhold, New York, NY, USA.
15. Exxon Chemical Company (1993) Vistanex® Polyisobutylene Properties and Applications (Bulletin 203-0493-0001), Exxon Corporation, Irving, TX, USA.
16. BASF (1997) Technical Information: Oppanol B Types (Bulletin TI/ES 1412e), BASF Corporation, Mount Olive, NJ, USA.
17. Schlademan, J.A. (1989) in Handbook of Pressure Sensitive Adhesive Technology (Satas, D., ed.), pp. 527-544, Van Nostrand Reinhold, New York, NY, USA.
18. Benedek, I. and Heymans, L.J. (1997) in Pressure-Sensitive Adhesives Technology, pp. 323-448, Marcel Dekker, New York, NY, USA.
19. Temin, S.C. (1990) in Handbook of Adhesives (3rd ed.) (Skeist, I., ed.), pp. 641-663, Van Nostrand Reinhold, New York, NY, USA.
20. Doyle, A. and Freeman, F.M. (1985) U.S. Patent 4,551,490.
21. Wang, K.S. et al. (1996) U.S. Patent 5,508,308.
22. Pfister W.R. Pharm. Technol. 13( 3):1989;126-138.
23. Pfister W.R. Drug and Cosmetic Industry. 143( 4):1988;44-52.
24. Pfister W.R. Adhesive Age. 33( 12):1990;20-24.
25. Pfister W.R., Woodard J.T., Grigoras S. Chem. Brit. 27( 1):1991;43-46.
26. Pfister W.R., Woodard J.T., Grigoras S. Pharm. Technol. 16( 1):1992;42-58.
27. Thomas X., Pfister W.R. S.T.P. Pharm Sciences. 1( 1):1991;38-46.
28. Sobieski, L.A. and Tangney, T.J. (1989) in Handbook of Pressure Sensitive Adhesive Technology (Satas, D., ed.), pp. 508-517, Van Nostrand Reinhold, New York, NY, USA.
29. Dow Corning (1996) BIO-PSA® Silicone Pressure Sensitive Adhesives (Bulletin 51-928A-96), Dow Corning Corporation, Midland, MI, USA.
30. Bhatt, P.P. and Raul, V.A. (1997) U.S. Patent 5,597,584.
31. Catelli C.et al. J. Pharm. Sci. 73:1983;316-317.
32. Satas, D. (1989) in Handbook of Pressure Sensitive Adhesive Technology (Satas, D., ed.), pp. 396-456, Van Nostrand Reinhold, New York, NY, USA.
33. Tan H.et al. Pharm. Res. 14( suppl.):1997;S-318.
34. Warson, H. (1986) European Adhesives and Sealant December, 4-14.
35. Li, C. et al. (1996) International Patent Application WO 96/40087.
36. Feldstein M.M.et al. Int. J. Pharm. 131:1996;229-242.
37. Feldstein, M.M. et al. (1996) in Prediction of Percutaneous Penetration (Vol. 4 b) (Brain, K.R., James, V.J. and Walters, K.A., eds), 56-60, STS Publishing, Cardiff, UK.
38. Vasiliev, A.E. et al. (1989) EP 0 340 307 A1.
39. Feldstein, M.M. et al. (1996) in Prediction of Percutaneous Penetration (Vol. 4 b) (Brain, K.R., James, V.J. and Walters, K.A., eds), 61-65, STS Publishing, Cardiff, UK.
40. Feldstein M.M. Proc. Int'l. Symp. Control. Release Bioact. Mater. 25:1998;848-849.
41. Duan, D.C. (1993) U.S. Patent 5,225,473.
42. Beckert T.E.et al. Proc. Int'l. Symp. Control. Release Bioact. Mater. 25:1998;571-572.
43. Lehman, K.O.R. (1996) in Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms (McGinity, J., ed.), 101-175, Marcel Dekker, New York, NY, USA.
44. Beier, H., Petereit, H.U. and Bergmann, G. (1994) U.S. Patent 5,296,512.
45. Kydonieus, A. et al. (1997) U.S. Patent 5,591,820.
46. Shah, K.R., Chang, T. and Kydonieus, A. (1998) U.S. Patent 5,714,543.
47. Zajaczkowski, M.J. (1998) U.S. Patent 5,726,250.
48. Krampe, S.E. (1987) U.S. Patent 4,693,776.
49. Therriault, D.J. and Rogers, K.W. (1996) U.S. Patent 5,573,778.
50. Therriault D. Pharm. Res. 13( Suppl.):1996;S-312.
51. Hariharan D., Chandran R. Pharm. Res. 13( Suppl.):1996;S-309.
52. Lee, C. and Ulman, K.L. (1990) U.S. Patent 4,898,920.
53. Appelt, M.R. and Grosh, S.K. (1996) EP 0 455 458 B1.
54. Asuma, M. et al. (1993) U.S. Patent 5,200,190.
55. Srinivasan, V. (1998) International Patent Application WO 98/03137.
56. Miranda, J. and Sablotsky, S. (1997) U.S. Patent 5,656,286.
57. Effing, J. et al. (1997) U.S. Patent 5,702,720.
58. Akemi, H. et al. (1997) U.S. Patent 5,683,710.
59. Sablotsky, S. and Gentile, J.A. (1997) U.S. Patent 5,686,099.